Ibogaine’s Surge in Popularity Could Be a Huge Loss for the...

Optimi Health To Supply MDMA For Therapist Experiential Training Program at...

Numinus Announces Partnership with MAPS to Support Therapist Psychedelic Experiential Training

Psychedelic Bulletin #139: Kentucky Earmarks $42m for Ibogaine Studies; Reunion Announces...

Numinus Appoints New Chief Financial Officer

PT415 – Psychedelic Science 2023: The Largest Psychedelic Conference in History

Silo Pharma Signs Agreement to Develop First-in-Class Ketamine Implant Therapeutic

PharmaTher Holdings Provides Corporate Update

Delix Therapeutics Appoints Aaron Koenig, MD as Chief Medical Officer

Wesana Health Announces Voting Results of AGSM

Load more